We are live on ! Find out more
HLTH

Cue Health Inc. Common Stock

Delisted

HLTH was delisted on the 5th of June, 2024.

86 hedge funds and large institutions have $371M invested in Cue Health Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 21 increasing their positions, 20 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

209% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 11

32% more funds holding

Funds holding: 6586 (+21)

17% more funds holding in top 10

Funds holding in top 10: 67 (+1)

5% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 20

7% less call options, than puts

Call options by funds: $5.05M | Put options by funds: $5.46M

29% less capital invested

Capital invested by funds: $521M → $371M (-$150M)

Holders
86
Holders Change
+21
Holders Change %
+32.31%
% of All Funds
1.36%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.11%
New
34
Increased
21
Reduced
20
Closed
11
Calls
$5.05M
Puts
$5.46M
Net Calls
-$401K
Net Calls Change
-$2.25M
Name Holding Trade Value Shares
Change
Change in
Stake
KI
1
Koch Industries
Kansas
$85M +$38.1M +4,206,669 +47%
OC
2
Oakmont Corp
California
$59.6M +$88.6M +9,789,997 New
DCMIC
3
Decheng Capital Management III (Cayman)
Cayman Islands
$57.9M +$81.2M +8,980,909 New
JJ
4
Johnson & Johnson
New Jersey
$35.8M
JPC
5
Jabodon PT Co
Nevada
$29.5M -$4.05M -447,357 -9%
Temasek Holdings
6
Temasek Holdings
Singapore
$20.2M
Capital World Investors
7
Capital World Investors
California
$11.3M -$5.65M -625,000 -26%
NCMU
8
NAYA Capital Management (UK)
United Kingdom
$10.2M -$7.69M -850,000 -35%
PA
9
Perceptive Advisors
New York
$10.2M
BL
10
Bleichroeder LP
New York
$6.45M
Goldman Sachs
11
Goldman Sachs
New York
$5.52M +$247K +27,356 +3%
RCM
12
RA Capital Management
Massachusetts
$4.84M
BlackRock
13
BlackRock
New York
$4.39M +$520K +57,458 +9%
FCOMV
14
Foresite Capital Opportunity Management V
California
$4.14M -$8.01M -885,620 -58%
FCMV
15
Foresite Capital Management V
California
$3.16M -$6.13M -677,236 -58%
MP
16
MSD Partners
New York
$2.55M -$7.15M -790,496 -67%
BRWA
17
B. Riley Wealth Advisors
Florida
$2.3M +$2.53M +279,795 +365%
FCMI
18
Foresite Capital Management IV
California
$1.7M -$6.72M -742,511 -74%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$1.45M -$61.1K -6,759 -3%
State Street
20
State Street
Massachusetts
$1.43M +$617K +68,224 +44%
Vanguard Group
21
Vanguard Group
Pennsylvania
$1.21M +$19.1K +2,117 +1%
National Bank of Canada
22
National Bank of Canada
Quebec, Canada
$1.2M +$240K +26,500 +17%
Ensign Peak Advisors
23
Ensign Peak Advisors
Utah
$1.13M
T. Rowe Price Associates
24
T. Rowe Price Associates
Maryland
$983K +$1.38M +152,385 New
HF
25
HRT Financial
New York
$821K +$1.15M +127,357 New

HLTH Hedge Fund Activity: Q1 2022 in Review

86 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Cue Health Inc. Common Stock (HLTH) for Q1 2022, worth a combined $371M — down 29% from $521M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new HLTH positions and 11 closed out — a net gain of 23 holders — while 21 added to existing stakes and 20 trimmed.

The largest buyer was Oakmont Corp, opening a new position worth an estimated $88.6M. The largest seller was Portolan Capital Management, exiting entirely with an estimated $10.6M sold.

  • 86 institutional investors held Cue Health Inc. Common Stock (HLTH) as of Q1 2022, up from 65 in Q4 2021.
  • Funds reported $371M of Cue Health Inc. Common Stock stock for Q1 2022, down 29% quarter-over-quarter.
  • 34 funds opened new Cue Health Inc. Common Stock positions in Q1 2022 and 11 closed out, a net change of +23 holders.
  • The largest Cue Health Inc. Common Stock buyer in Q1 2022 was Oakmont Corp, an estimated $88.6M added.
  • The largest Cue Health Inc. Common Stock seller in Q1 2022 was Portolan Capital Management, an estimated $10.6M sold.

Based on aggregated 13F filings for Q1 2022.